Indivior to pay $385m to settle Suboxone monopoly case

Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.

Related Keywords

Mark Crossley , ,Indivior ,R85m ,Settle ,Suboxone ,Monopoly ,Case ,Category All ,Category Company News ,Category News And Announcements ,Category Ifa News Round Up ,Category Headline News ,Category Fidelity Top Stories ,Category Sectorial Health Technology ,